Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cytovance Wins BiologicsMD Contract | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cytovance Wins BiologicsMD Contract

Will develop osteoporosis drug for Phase I trials

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cytovance Biologics has been awarded a manufacturing contract to continue development of BiologicMD’s osteoporosis drug, PTH-CBD. The agreement will lead to the development of the manufacturing platform that will allow BiologicsMD to conduct Phase I studies.
 
“We are excited to announce our partnership with Cytovance to develop the manufacturing platform for our PTH-CBD treatment. Their expertise will play a key role in accelerating the development of this compound that will hopefully improve the lives of the millions of individuals who suffer from osteoporosis,” said Paul Mlakar, Jr., president of BiologicsMD.
 
“Cytovance is excited that BiologicsMD has chosen us to support this innovative treatment for osteoporosis,” said Darren Head, president and chief executive officer of Cytovance Biologics. “Our experienced staff and state-of-the-art facilities are prepared to deliver the highest quality of manufacturing services for successful completion of this clinical milestone for the PTH-CBD program.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics